Investigador REGINA (María Rostworowski I)
Entrenamiento: Médico Cirujano, Magister en Salud Pública
Oficina: Escuela Profesional de Medicina
Av. Juan Antonio Lavalle S/N, Ex-Hacienda Villa, Lima 09, Perú
Proyectos en ejecución:
- Expresión DDT4 como nuevo Biomarcador de Pronostico en Glioblastoma.
Publicaciones:
- Pinto JA, Pinillos L, Villarreal-Garza C, Morante Z, Villarán MV, Mejía G, Caglevic C, Aguilar A, Fajardo W, Usuga F, Carrasco M, Rebaza P, Posada AM, Tirado-Hurtado I, Flores C, Vallejos CS. Barriers in Latin America for the management of locally advanced breast cancer. Ecancermedicalscience. 2019 Jan 22;13:897. doi: 10.3332/ecancer.2019.897. eCollection 2019. Review. PubMed PMID: 30792814; PubMed Central PMCID: PMC6372299.
- Tirado-Hurtado I, Carlos C, Lancho L, Alfaro A, Ponce R, Schwarz LJ, Torres L, Ayudant M, Pinto JA, Fajardo W. Helicobacter pylori: History and facts in Peru. Crit Rev Oncol Hematol. 2019 Feb;134:22-30. doi: 10.1016/j.critrevonc.2018.12.005. Epub 2018 Dec 19. PubMed PMID: 30771870.
- Aguilar A, Pinto JA, Araujo J, Fajardo W, Bravo L, Pinillos L, Vallejos C. Control of cervical cancer in Peru: Current barriers and challenges for the future. Mol Clin Oncol. 2016 Aug;5(2):241-245. Epub 2016 Jun 10. PubMed PMID: 27446557; PubMed Central PMCID: PMC4950606.
- Tirado-Hurtado I, Fajardo W, Pinto JA. DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer. Front Oncol. 2018 Apr 12;8:106. doi: 10.3389/fonc.2018.00106. eCollection 2018. Review. PubMed PMID: 29707520; PubMed Central PMCID: PMC5906527.
- Pinto JA, Rolfo C, Raez LE, Prado A, Araujo JM, Bravo L, Fajardo W, Morante ZD, Aguilar A, Neciosup SP, Mas LA, Bretel D, Balko JM, Gomez HL. In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies. Sci Rep. 2017 May 8;7(1):1526. doi: 10.1038/s41598-017-01207-3. PubMed PMID: 28484222; PubMed Central PMCID: PMC5431475.
- Martínez V, Navarro C, Cano C, Fajardo W, Blanco A. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data. Artif Intell Med. 2015 Jan;63(1):41-9. doi: 10.1016/j.artmed.2014.11.003. Epub 2015 Jan 13. PubMed PMID: 25704113.
